LCO No. 937 1 of 1
General Assembly Proposed Bill No. 27
January Session, 2019
LCO No. 937
Referred to Committee on HUMAN SERVICES
Introduced by:
SEN. LOONEY, 11th Dist.
AN ACT REDUCING PRESCRIPTION DRUG PRICES UNDER THE
MEDICAID PROGRAM.
Be it enacted by the Senate and House of Representatives in General
Assembly convened:
That chapter 319v of the general statutes be amended to authorize 1
the Commissioner of Social Services to reduce prescription drug costs 2
under the Medicaid program by establishing: (1) A price cap that 3
requires (A) additional negotiation for prescription drug rebates with 4
manufacturers and review by the board established pursuant to 5
section 17b-274d of the general statutes whenever the cap is exceeded, 6
and (B) further restrictions on prescription drug purchases and 7
transparency regarding actual prescription drug manufacturing costs 8
when negotiations fail, and (2) a transparent reimbursement model for 9
pharmaceutical benefit managers that allows the state Medicaid 10
program to pay the discounted cost for prescription drugs negotiated 11
by such managers. 12
Statement of Purpose:
To lower health care costs under the Medicaid program.